CSNK2A1 Foundation released Episode 6 of Roadmap to Rare on Wednesday, September 9.
Published
Signal category
Presence & Recognition
Quote
“Episode 6 of Roadmap to Rare drops Wednesday, September 9!”
— CSNK2A1 Foundation team
Company
CSNK2A1 Foundation
We are focused on finding a cure for Okur-Chung Neurodevelopmental Syndrome.
- Industry
- Philanthropic Fundraising Services
- Location
- San Francisco, US
- Company size
- 15 employees
CSNK2A1 Foundation is focused on finding a cure for Okur-Chung Neurodevelopmental Syndrome and ensuring affected individuals have the opportunities and supports necessary for happy and full lives. CSNK2A1 Foundation is operated and funded through a committed team of volunteers, advocates and researchers. We aim to accomplish our mission by: * financing and encouraging meaningful research, * providing support to individuals affected and those that care for and love them, * promoting awareness, * educating patients, caregivers and health professionals and * advocating for issues important to our community. Okur-Chung Neurodevelopmental Syndrome is a rare genetic disorder first identified in 2016. OCNDS is caused by a mutation in the CSNK2A1 gene which is located on Chromosome 20. The gene CSNK2A1 creates a protein called CK2 which plays a crucial role in development. A mutation in this gene disrupts typical development. CSNK2A1 Foundation is a 501(c)(3) non-profit organization. EIN #82-4220939
Founded 2018